Susquehanna International Group’s Alterity Therapeutics ATHE Stock Holding History

Susquehanna International Group’s Portfolio ATHE Stock Details ATHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-355	Closed	-$19K	–	9387
2015 Q3	$19K	Sell	355 -770	-68%	-$48.8K	﹤0.01%	9505
2015 Q2	$79K	Buy	1,125 +768	+215%	+$57.7K	﹤0.01%	9753
2015 Q1	$24K	Sell	357 -263	-42%	-$21K	﹤0.01%	9255
2014 Q4	$61K	Sell	620 -1,493	-71%	-$161K	﹤0.01%	9322
2014 Q3	$271K	Buy	2,113 +106	+5%	+$14.2K	﹤0.01%	8172
2014 Q2	$272K	Sell	2,007 -12,326	-86%	-$1.41M	﹤0.01%	8547
2014 Q1	$2.41M	Buy	14,333 +10,255	+251%	+$5.67M	﹤0.01%	4026
2013 Q4	$1.72M	Buy	4,078 +3,790	+1,316%	+$1.13M	﹤0.01%	4553
2013 Q3	$71K	Buy	+288	New	+$66.1K	﹤0.01%	8176

Other funds holding ATHE

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HWM

HB Wealth Management Atlanta, Georgia $15.5B AUM 18.35% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

TLCM

Twin Lakes Capital Management Redwood Shores, California $220M AUM 31.75% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

SWM

Sugarloaf Wealth Management Duluth, Georgia $529M AUM 14.14% 1-Year Est. Return

Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return

Susquehanna International Group's ATHE Position: Q4 2024 in Review

Susquehanna International Group sold out of Alterity Therapeutics (ATHE) in Q4 2024, closing a stake of 13,932 shares — an estimated $18.7K sold.

Susquehanna International Group first reported a position in ATHE in Q3 2013 and held it in 17 quarters. The position peaked at $706K in Q1 2014. 13 funds tracked by Wall St. Rank hold ATHE as of Q4 2024.

Susquehanna International Group reported no remaining Alterity Therapeutics position as of Q4 2024 after selling out during the quarter.
Susquehanna International Group sold 13,932 Alterity Therapeutics shares in Q4 2024, an estimated $18.7K.
Susquehanna International Group first reported a position in Alterity Therapeutics in Q3 2013 and held it in 17 quarters.
Susquehanna International Group's Alterity Therapeutics position peaked at $706K in Q1 2014.
13 funds tracked by Wall St. Rank held Alterity Therapeutics as of Q4 2024.

Based on Susquehanna International Group's 13F filing for Q4 2024, filed 14 Feb 2025.